ÂÜÀòÂÒÂ×

Susan Mou, Ph.D. currently serves as the Chief Executive Officer at CorrectSequence Therapeutics, focusing on pipeline development, business development, fundraising, and general operations. In addition, Susan is an expert in the IFPMA-ICH-Cell and Gene Therapies Discussion Group. Previously, Susan held multiple leadership positions at WuXi Biologics, including Vice President and Head of Microbial and Viral Platforms, where responsibilities included building the CDMO service and overseeing the global supply chain. Earlier experience includes roles at MSD and Pfizer, where Susan contributed to biologics development and analytical chemistry projects. Susan holds a Ph.D. in Analytical Chemistry and Chemical Biology from Rensselaer Polytechnic Institute and a Bachelor of Science in Chemistry from Fudan University.